<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18579990</article-id><article-id pub-id-type="pmc">2636167</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_4_307_39662</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A pre- and post-treatment evaluation of vision-related quality of life in uveitis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Venkataraman</surname><given-names>Arvind</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><degrees>MD</degrees></contrib></contrib-group><aff>Aravind Eye Hospital and Postgraduate Institute of Ophthalmology(AV, SRR), Madurai, India, Gimbel Eye Centre (AV), Calgary,Canada</aff><author-notes><corresp id="cor1">Correspondence to Dr. Venkataraman Arvind, Aravind Eye Hospitaland PG Institute of Ophthalmology, 1, Anna Nagar, Madurai - 625 020,India. Email: <email>chakraraja@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2008</year></pub-date><volume>56</volume><issue>4</issue><fpage>307</fpage><lpage>312</lpage><history><date date-type="received"><day>12</day><month>9</month><year>2007</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2008</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Aim:</title><p>To study the effect of treatment on vision-related quality of life (VR-QOL) in uveitis patients.</p></sec><sec><title>Materials and Methods:</title><p>Interviewer-administered questionnaire-based evaluation of visual function andVR-QOL in Tamil-speaking adult patients with active uveitis at presentation and follow-up by the sameinterviewer.</p></sec><sec><title>Results:</title><p>Ninety-eight patients participated in this study. There was a statistically significant improvementin VR-QOL in all the scales following treatment (<italic>P</italic> &#x0003c; 0.001). Patients with chronic uveitis showed betterimprovement upon treatment than patients with acute uveitis. The visual symptoms scale showed moderategains following treatment (effect size 0.56). Persons with bilateral disease had poorer mean scores comparedto those with unilateral disease. Visual acuity was closely correlated with VR-QOL scores.</p></sec><sec><title>Conclusion:</title><p>The VR-QOL measurement has shown that it is sensitive to demonstrate the problems ofpatients with uveitis irrespective of their demographic profile. The scores improved significantly in patientswith uveitis following treatment and have shown close correlation to visual acuity thus demonstrating thatVR-QOL is effective in assessing the response to treatment.</p></sec></abstract><kwd-group><kwd>Indian vision function questionnaire</kwd><kwd>uveitis</kwd><kwd>vision-related quality of life</kwd><kwd>visual acuity</kwd></kwd-group></article-meta></front><body><p>Patient-reported outcomes have been studied extensively, andare widely accepted tools for measuring patients&#x02032; perceptionsof their vision in a variety of diseases and are now used inclinical trials to evaluate the efficacy of medical or surgicalinterventions. In ophthalmological research, both health-related quality of life (QOL) and vision-related (VR) QOL arerelevant measures.<xref ref-type="bibr" rid="ref1">1</xref> Vision-related QOL has been evaluatedin various ocular conditions<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref6">6</xref> and ophthalmologicsurgical interventions.<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref></p><p>Uveitis is composed of a diverse group of disease entities,which in aggregate have been estimated to cause approximately10% of blindness.<xref ref-type="bibr" rid="ref11">11</xref> Reports from Western populations indicatethat uveitis causes a profound decrease in vision and health-related QOL and VR-QOL instruments have been used toevaluate the outcomes of treatment of ocular disease.<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref> Uveitiscauses vision loss both directly through inflammation andvia complications such as macular edema, glaucoma, cataractand others<xref ref-type="bibr" rid="ref12">12</xref> each of which is expected to affect VR-QOLmeasurements. Because treatment for uveitis itself can result inboth ocular and systemic complications, it would be valuableto assess the impact of such treatment on QOL and VR-QOLto evaluate the presumed benefit of such treatment frompatients&#x02032; perspectives. Our study was planned to look at theVR-QOL issues in uveitis in the Indian subcontinent since theincidence of infective uveitis is greater and the customs andneeds of this population are entirely different from that of theWestern population.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><p>It was a prospective study of changes in VR-QOL followingtreatment for uveitis in Tamil-speaking south Indian patientsreceiving care for uveitis at a large, tertiary center.</p><p>This study was a questionnaire-based assessment of VR-QOLin uveitis patients, conducted at the Uvea Clinic at a tertiaryeye care center from southern India from December 2005 toJune 2006. Ninety-eight consecutive Tamil-speaking adults(&#x0003e;15 years) who were diagnosed with active uveitis, who hadnot previously been treated for this condition were included inthe study. The 33-item Tamil version of Indian vision functionquestionnaire (IND-VFQ)<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref14">14</xref> was applied to all thepatients by the same interviewer. A complete ophthalmic evaluation andnecessary investigations were done for each individual patient,the findings were recorded, and treatment was administered asclinically indicated. Socio-demographic data were also collected.The patients repeated the same questionnaire, administered bythe same interviewer, at follow-up.</p><p>Because of cultural and linguistic considerations, it ismandatory to use a questionnaire developed for a particularcommunity and in the native language of that population,which is responsive to the experience of the population tobe evaluated.<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref> The 33-item Tamil version of IND-VFQused in this study was developed to address these concerns inour community.<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref14">14</xref> Testing of the IND-VFQ forreliability (Cronbach&#x02032;s alpha &#x0003e;0.70),<xref ref-type="bibr" rid="ref15">15</xref> validity and consistency indicatethat it is appropriate for use in clinical research.<xref ref-type="bibr" rid="ref14">14</xref></p><p>The IND-VFQ (Appendix 1) has three scales, which area 21-item section for general function, a five-item sectionfor psychosocial impact and a seven-item section for visualsymptoms. The items in the general function cover mobility,household performance, economic activity, and activities ofdaily living. The psychosocial scale have items concerning social,family and personal wellbeing. The visual symptoms have itemslike vision, photophobia and glare. A four-point response scaleassesses visual symptoms and psychosocial impact: 1 (best score)to 4 (worst score). The general functioning questions have a fivepoint scale from 1 (best score) to 5 (worst score).<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref14">14</xref> For each scale, a composite score was calculated as the cumulative total ofindividual responses expressed as a percentage of the maximumscore possible and then transformed such that 100 representedthe best possible score (no difficulty with any of the items in thatscale) and 0 the worst score (maximum difficulty in that scale).</p><p>Effect size (ES)<xref ref-type="bibr" rid="ref16">16</xref>-<xref ref-type="bibr" rid="ref17">17</xref> and paired t-test analysiswas done comparing the pre- and post-treatment scores to establishthe changes in VR-QOL associated with treatment of uveitis.The ES is defined as the mean change in IND-VFQ score atfollow-up divided by its standard deviation at baseline. TheES reflects the magnitude of change in IND-VFQ in responseto treatment commenced at baseline. Cohen defines an ES of0.2 as small change, 0.5 as medium change and 0.8 or greatera large change.<xref ref-type="bibr" rid="ref17">17</xref> Demographic (age, sex, education, placeof residence and occupation) and clinical characteristics(anatomical entities, pathology, laterality) were evaluated forpotential relationships to change in VR-QOL. The relationshipbetween level of visual acuity and VR-QOL was also evaluatedusing Spearman analysis.</p><p>The study was conducted under the supervision of theInstitutional Review Board of our hospital, in accordance withthe principles of the Declaration of Helsinki.</p></sec><sec><title>Results</title><p>Ninety-eight consecutive patients agreed to participate in thestudy, with no refusals. Sixty-seven (68.3%) of these returned forfollow-up and completed the questionnaire a second time afteran average of 30.5 days (range 24-59). The socio-demographiccharacteristics of these patients and those who came for follow-up are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p><p>The mean age was 35.24 years (range 16-69) and 39% ofthe patients were females. A total of 20 patients (20%) wereilliterate. Sixty-three per cent of patients were employed.</p><p>According to the International Uveitis Study Groupclassification,<xref ref-type="bibr" rid="ref18">18</xref>-<xref ref-type="bibr" rid="ref19">19</xref> 51% had anterior uveitis,10.2% had intermediate uveitis, 19.4% had posterior uveitis and 19.4% hadpan-uveitis. Disease was idiopathic in 44.9% and tuberculosiswas the most common specific disease underlying uveitis(14.3%). None of the patients had previously been treatedexcept with topical medications since any treatment otherthan topical steroids was an exclusion criterion. All of themhad active uveitis and required some form of treatment.Ninety-four patients needed only topical corticosteroids, sevenpatients needed peri-ocular corticosteroids (posterior sub-Tenoninjections), 25 patients were given oral corticosteroids and fivepatients needed immunosuppressives. Twenty-nine patientshad an infectious cause and were treated for the specific diseaseconcerned (anti-tuberculous, anti-toxoplasma or anti-viral) withor without the other drugs mentioned previously. The binocularvisual acuity range was light perception to 20/20. There wasa loss to follow-up of 31 (31.6%) patients. The most commonreason for failure to complete the study was planned follow-upelsewhere. The baseline and clinical characteristics of thosecompleting and lost to follow-up were similar [<xref ref-type="table" rid="T1">Table 1</xref>].</p><p>This 21-item general function scale showed a highly statisticallysignificant improvement following treatment (<italic>P</italic> &#x0003c; 0.001). The ESshowed a moderate improvement in general function in allsubgroups of uveitis except for posterior uveitis, which hadgreater improvement (large ES 0.08). The mean score was 90.7 atbaseline and improved to 95.5 at follow-up [<xref ref-type="table" rid="T2">Table 2</xref>].</p><p>Illiterates showed much better improvement in visualfunction on treatment than literates (ES: 0.47 vs. 0.32). Similarly,females showed better visual function scores at follow-up. Themean scores were lowest for the &#x0003c;25 years age group (94.7) andhighest for the &#x0003e;50 years age group (96.83).</p><p>The psychosocial impact scale showed statistically significantimprovement on treatment (<italic>P</italic> &#x0003c; 0.001). The ES was the least forthis scale compared to the visual function and visual symptomsscales. Chronic uveitis showed better improvement (ES 0.71)compared to acute uveitis (ES 0.23). The psychosocial gain wasmore for posterior uveitis than other anatomical entities. Thedifference in mean pre- and post-treatment scores was lessfor illiterates and females than for literates and males. Maleand literate population showed better gains in this scale aftertreatment.</p><p>Psychosocial scale has shown that patients with chronicuveitis demonstrated comparatively better improvementin VR-QOL than those with acute uveitis, perhaps becauselongstanding inflammation may have had more time toaffect lifestyle than recent onset disease. Self-reported visualsymptoms were worse among the subgroups like those fromrural communities and among illiterates and they have showngreater improvement following treatment compared to theurban and literate population.</p><p>The baseline seven-item visual symptoms scale resultswere lower than General Function and Psychosocial Impactscale scores in our patients with uveitis, across a wide range ofsubgroups, and likewise the improvement with treatment waslarger. The difference was statistically significant (<italic>P</italic> &#x0003c; 0.001).Maximum gain was noted for posterior uveitis (ES 0.63) andgranulomatous uveitis in their respective groupings (ES0.73). Illiterates, rural and female populations showed betterimprovement than their respective counterparts. The Spearmananalysis was used to correlate changes in visual acuity andVR-QOL at baseline and follow-up. All the scales showed amoderate to good correlation with visual acuity as is usual forany VR-QOL assessment (<italic>r</italic> = 0.51).</p></sec><sec><title>Discussion</title><p>This questionnaire-based assessment of uveitis patients isthe first study on VR-QOL in uveitis patients in the Indiansubcontinent, applying a questionnaire developed and validatedspecifically for the Tamil-speaking population. The studyconfirms results from other regions that VR-QOL is affected inpatients with uveitis<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref> and that treatment results in statisticallysignificant improvement in all the scales of VR-QOL.</p><p>Patients with posterior uveitis showed more improvementthan either anterior or intermediate uveitis. This may beattributed to the fact that their baseline problems were greaterthan the rest and hence showed better results on follow-up. Thesubgroups comprising employed, males and literates agreedto greater difficulties in general function, possibly becausethey are the traditional breadwinners in a family in India, andmay have greater social and economic demands than theircounterparts. It was noted that the incidence was higher amongmales than females as seen in other studies done in India,<xref ref-type="bibr" rid="ref20">20</xref>-<xref ref-type="bibr" rid="ref24">24</xref> but studies in the western world have shown that femaleshave a greater incidence and prevalence.<xref ref-type="bibr" rid="ref11">11</xref> This difference ina developing country may be related to various factors. Onemay be the social structure where males are the breadwinnersof the family and hence more number of males attend theclinic.<xref ref-type="bibr" rid="ref22">22</xref> A second factor may be related to higher incidence ofinfectious uveitis due to tuberculosis, leptospirosis and riverwater granulomas among males than females as a result ofexposure due to their occupation in rural areas.<xref ref-type="bibr" rid="ref25">25</xref>-<xref ref-type="bibr" rid="ref29">29</xref>In spite of showing statistically significant improvement we find thatthe mild uveitis, especially anterior and intermediate uveitishad scores close to the ceiling at baseline. Hence the recordedimprovement may not show the real impact. This problem offloor/ceiling effect has been noted in different QOL studiesdone earlier. But the ceiling effect in our study is not very highto affect the reliability of this study.<xref ref-type="bibr" rid="ref30">30</xref></p><p>The study also found a greater disparity between the ruraland urban populations especially on the psychosocial scales. Thismay be explained by the rural populations being employed inopen fields and being daily wage earners and hence incur morefinancial burden due to the disease which in turn affects theperception of the disease. This indicates that in this subcontinentthere cannot be a generalization to evaluate VR-QOL outcomesunlike the western world since there is greater disparity in theneeds among different sub-sects of the population.</p><p>In our study, both granulomatous and non-granulomatoussubtypes showed significant gains following treatment,but granulomatous entities fared comparatively better.Granulomatous cases often are of infectious etiology in thispart of the world.<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref31">31</xref> In our study, 30% of uveitis cases wereof infectious origin. The treatment regimens available forinfectious uveitis appear to result in an equally favorable impacton VR-QOL in these patients. The VR-QOL study by Gardiner<italic>et al</italic>. has shown that the younger populations with uveitis havepoor VR-QOL than the older population.<xref ref-type="bibr" rid="ref5">5</xref> This is seen in ourpopulation as well and more so for psychosocial items. Thescores were worse for bilateral disease than for unilateral diseaseand this is similar to the observations of Brown <italic>et al</italic>.<xref ref-type="bibr" rid="ref32">32</xref></p><p>There are a few limitations in our study. The first limitationis the loss to follow-up and the duration of follow-up. Thoughnot all the patients turned up for follow-up the demographicsand clinical characteristics were similar and hence should notcause significant changes to the final result. The follow-upassessment was done based on clinical improvement and nottreatment completion. But the disease was well controlledduring the follow-up assessment and hence on taperingschedule of medications and this meant fairly similar VR-QOL.Second being the diverse nature and treatments involved inthese patients. It would need a larger study to really explainthe effects of each entity on VR-QOL. Third limitation is theceiling effect as explained earlier. Long-term changes in VR-QOL such as are likely to occur in some forms of chronic uveitiscould not be addressed by this study, which had only short-term follow-up. It would be of interest to evaluate QOL over alonger follow-up period, which would allow evaluation of thenet QOL impact of systemic therapies known to have potentialsystemic side-effects.</p><p>In conclusion, this study has shown that VR-QOL isadversely affected by uveitis, even in mild anterior uveitis, andthat there is significant improvement in VR-QOL followingtreatment.</p></sec></body><back><fn-group><fn><p>Source of Support: Nil</p></fn><fn><p>Conflict of Interest: None declared</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzpatrick</surname><given-names>R</given-names></name><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Gore</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Spiegelhalter</surname><given-names>D</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name></person-group><article-title>Quality of life measures in health care, I: Applications and issues in assessment</article-title><source>BMJ</source><year>1992</year><volume>305</volume><fpage>1074</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1467690</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffman</surname><given-names>RM</given-names></name><name><surname>Jacobsen</surname><given-names>G</given-names></name><name><surname>Whitcup</surname><given-names>SM</given-names></name></person-group><article-title>Visual functioning andgeneral health status in patients with uveitis</article-title><source>Arch Ophthalmol</source><year>2001</year><volume>119</volume><fpage>841</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11405835</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BL</given-names></name><name><surname>Wilson</surname><given-names>MR</given-names></name></person-group><article-title>Health-related quality of life in patients withcataract and glaucoma</article-title><source>J Glaucoma</source><year>2000</year><volume>9</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10708237</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GL</given-names></name><name><surname>Brown</surname><given-names>MM</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Difference betweenophthalmologists and patients perception of quality of life associatedwith age-related macular degeneration</article-title><source>Can J Ophthalmol</source><year>2000</year><volume>35</volume><fpage>127</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10812481</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>AM</given-names></name><name><surname>Armstrong</surname><given-names>RA</given-names></name><name><surname>Dunne</surname><given-names>MC</given-names></name><name><surname>Murray</surname><given-names>PL</given-names></name></person-group><article-title>Correlationbetween visual function and visual ability in patients with uveitis</article-title><source>Br J Ophthalmol</source><year>2002</year><volume>86</volume><fpage>993</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12185125</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>CC</given-names></name><name><surname>Hughes</surname><given-names>EH</given-names></name><name><surname>Frost</surname><given-names>NA</given-names></name><name><surname>Dick</surname><given-names>AD</given-names></name></person-group><article-title>Quality of lifeand visual function in patients with intermediate uveitis</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>1151</fpage><lpage>65</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellwein</surname><given-names>LB</given-names></name><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Negrel</surname><given-names>AD</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name></person-group><article-title>Quality of lifeassessment in blindness prevention interventions</article-title><source>Int Ophthalmol</source><year>1994</year><volume>18</volume><fpage>263</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7607806</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliser</surname><given-names>JE</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name><name><surname>Rahmathullah</surname><given-names>R</given-names></name><name><surname>Baburajan</surname><given-names/></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Tielsch</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Vision-specific function and quality of lifeafter cataract extraction in south India</article-title><source>J Cataract Refract Surg</source><year>1998</year><volume>24</volume><fpage>222</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9530597</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natchiar</surname><given-names>GN</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name><name><surname>Negrel</surname><given-names>D</given-names></name></person-group><article-title>The Madurai intraocularlens study, I: A randomized clinical trial comparing intracapsularcataract extraction and extra capsular cataract extraction andextracapsular cataract extraction with posterior chamberintraocular lens</article-title><source>Am J Ophthalmol</source><year>1998</year><volume>125</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9437308</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Vijayakumar</surname><given-names>V</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name><name><surname>Ellwein</surname><given-names>LB</given-names></name></person-group><article-title>The Madurai intraocular lens study III: Visual functioning andquality of life outcomes</article-title><source>Am J Ophthalmol</source><year>1998</year><volume>125</volume><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">9437310</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussenblatt</surname><given-names>RB</given-names></name></person-group><article-title>The natural history of uveitis</article-title><source>Int Ophthalmol</source><year>1990</year><volume>14</volume><fpage>303</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2249907</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothova</surname><given-names>A</given-names></name><name><surname>Suttorp-van Schulten</surname><given-names>MS</given-names></name><name><surname>Frits Treffers</surname><given-names>W</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><article-title>Causes and frequency of blindness in patients with intraocularinflammatory disease</article-title><source>Br J Ophthalmol</source><year>1996</year><volume>80</volume><fpage>332</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8703885</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>GV</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name><name><surname>Viswanalh</surname><given-names>K</given-names></name><name><surname>Donoghue</surname><given-names>EM</given-names></name><name><surname>Fletcher</surname><given-names>AE</given-names></name></person-group><article-title>The development of the Indian vision functionquestionnaire content</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">15774932</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Viswanath</surname><given-names>K</given-names></name><name><surname>Thulsairaj</surname><given-names>RD</given-names></name><name><surname>Murthy</surname><given-names>GV</given-names></name><name><surname>Lamping</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><etal/></person-group><article-title>The development of the Indian vision functionquestionnaire: Field testing and psychometric evaluation</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>621</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15834097</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronbach</surname><given-names>LJ</given-names></name></person-group><article-title>Co-efficient alpha and the internal structure of test</article-title><source>Psychometrika</source><year>1951</year><volume>16</volume><fpage>297</fpage><lpage>334</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazis</surname><given-names>LE</given-names></name><name><surname>Anderson</surname><given-names>JJ</given-names></name><name><surname>Meenan</surname><given-names>RF</given-names></name></person-group><article-title>Effect sizes for interpretingchanges in health status</article-title><source>Med Care</source><year>1989</year><volume>27</volume><fpage>S178</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">2646488</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioural sciences</source><year>1988</year><edition>2nd ed</edition><publisher-loc>Hillsdale, NJ</publisher-loc><publisher-name>Lawrence Erlbaum Associates</publisher-name></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch-Michel</surname><given-names>E</given-names></name><name><surname>Nussenblatt</surname><given-names>RB</given-names></name></person-group><article-title>International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease</article-title><source>Am J Ophthalmol</source><year>1987</year><volume>103</volume><fpage>234</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3812627</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabs</surname><given-names>DA</given-names></name><name><surname>Nussenblatt</surname><given-names>RB</given-names></name><name><surname>Rosenbaum</surname><given-names>JT</given-names></name></person-group><article-title>Standardization of uveitis nomenclature for reporting clinical data: Results of the First InternationalWorkshop</article-title><source>Am J Ophthalmol</source><year>2005</year><volume>150</volume><fpage>509</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16196117</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Ganesh</surname><given-names>SK</given-names></name></person-group><article-title>Pattern of uveitis in a referral uveitisclinic in India</article-title><source>Indian J Ophthalmol</source><year>1995</year><volume>43</volume><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8822485</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Narain</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Ganesh</surname><given-names>SK</given-names></name></person-group><article-title>Pattern of uveitis in referraluveitis clinic in India</article-title><source>Int Ophthalmol</source><year>1996</year><volume>20</volume><fpage>223</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9112191</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consul</surname><given-names>BN</given-names></name><name><surname>Sharma</surname><given-names>DP</given-names></name><name><surname>Chhabra</surname><given-names>HN</given-names></name><name><surname>Sahai</surname><given-names>R</given-names></name></person-group><article-title>Uveitis: Etiological pattern in India</article-title><source>The Eye Ear Nose Throat Monthly</source><year>1995</year><volume>146</volume><fpage>2</fpage><lpage>7</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Cunningham</surname><given-names>ET</given-names><suffix>Jr</suffix></name></person-group><article-title>Infectious causes of uveitis inthe developing world</article-title><source>Int Ophthalmol Clin</source><year>2000</year><volume>40</volume><fpage>137</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">10791262</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Namperumalsamy</surname><given-names>P</given-names></name></person-group><article-title>Global variation and patternchanges in epidemiology of uveitis</article-title><source>Indian J Ophthalmol</source><year>2007</year><volume>55</volume><fpage>173</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">17456933</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Namperumalsamy</surname><given-names>P</given-names></name></person-group><article-title>Leptospirosis</article-title><source>Ocul Immunol Inflamm</source><year>1999</year><volume>7</volume><fpage>109</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10420207</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name></person-group><article-title>Leptospirosis</article-title><source>Curr Opin Ophthalmol</source><year>2002</year><volume>13</volume><fpage>381</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12441841</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Rathnam</surname><given-names>S</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Dean</surname><given-names>D</given-names></name><name><surname>Nozik</surname><given-names>RA</given-names></name><name><surname>Namperumalsamy</surname><given-names>P</given-names></name></person-group><article-title>Uveitis associated with an epidemic outbreakof leptospirosis</article-title><source>Am J Ophthalmol</source><year>1997</year><volume>124</volume><fpage>71</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9222235</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Usha</surname><given-names>KR</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name></person-group><article-title>Presumed Trematodegranulomas of anterior chamber: A newly recognized causeof uveitis in children from South India</article-title><source>Am J Ophthalmol</source><year>2002</year><volume>133</volume><fpage>773</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12036668</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>R</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name><name><surname>Santha</surname><given-names>T</given-names></name><name><surname>Gopi</surname><given-names>PG</given-names></name><name><surname>Subramani</surname><given-names>R</given-names></name><name><surname>Chandrasekaran</surname><given-names>V</given-names></name><etal/></person-group><article-title>Gender disparities in tuberculosis: Reportfrom a rural DOTS programme in south India</article-title><source>Int J Tuberc Lung Dis</source><year>2004</year><volume>8</volume><fpage>323</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15139471</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stucki</surname><given-names>G</given-names></name><name><surname>Stucki</surname><given-names>S</given-names></name><name><surname>Br&#x000fc;hlmann</surname><given-names>P</given-names></name><name><surname>Michel</surname><given-names>BA</given-names></name></person-group><article-title>Ceiling effects ofhealth assessment questionnaire and its modified version in someambulatory rheumatoid arthritis patients</article-title><source>Ann Rheumat Dis</source><year>1995</year><volume>54</volume><fpage>461</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7632087</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name></person-group><article-title>Pattern of uveitis in a referral eye clinicin north India</article-title><source>Indian J Ophthalmol</source><year>2004</year><volume>52</volume><fpage>121</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15283216</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MM</given-names></name><name><surname>Brown</surname><given-names>GC</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Busbee</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>H</given-names></name></person-group><article-title>Qualityof life associated with unilateral and bilateral good vision</article-title><source>Ophthalmology</source><year>2001</year><volume>108</volume><fpage>643</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11297474</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Socio-demographic data and clinical characteristics at baseline and follow-up</p></caption><alt-text>Table 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-307-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>VR-QOL outcomes following treatment for different subgroups</p></caption><alt-text>Table 2</alt-text><graphic xlink:href="IndianJOphthalmol-56-307-g002"/></table-wrap></floats-group></article>